Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Thermo Fisher Scientific Inc (TMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 71,272,456
  • Shares Outstanding, K 391,220
  • Annual Sales, $ 18,274 M
  • Annual Income, $ 2,022 M
  • 36-Month Beta 1.06
  • Price/Sales 3.89
  • Price/Cash Flow 14.21
  • Price/Book 3.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
172.13 +5.84%
on 06/27/17
182.86 -0.37%
on 07/21/17
+6.58 (+3.75%)
since 06/21/17
3-Month
156.03 +16.76%
on 04/24/17
182.86 -0.37%
on 07/21/17
+27.14 (+17.51%)
since 04/21/17
52-Week
139.07 +31.00%
on 12/01/16
182.86 -0.37%
on 07/21/17
+25.98 (+16.63%)
since 07/21/16

Most Recent Stories

More News
Will Stryker (SYK) Deliver a Beat this Earnings Season?

The growing adoption of Stryker's (SYK) MAKO robots is expected to drive second-quarter 2017 sales in the orthopedic and reconstructive surgery market.

SYK : 146.19 (-0.82%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
ALGN : 158.87 (-0.81%)
Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.

SYK : 146.19 (-0.82%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
RMD : 77.00 (-1.32%)
Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock?

Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.

DXTR : 0.26 (unch)
BSX : 27.62 (-0.40%)
TMO : 182.18 (+0.35%)
TFX : 211.17 (-0.66%)
McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

SYK : 146.19 (-0.82%)
MCK : 165.92 (+0.51%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?

IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.

SYK : 146.19 (-0.82%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
IDXX : 166.62 (-0.40%)
LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards?

With the Covance Drug Diagnostic arm's revenue and margins projected to decline further, LabCorp???s business in Q2 might face disruption.

DXTR : 0.26 (unch)
TMO : 182.18 (+0.35%)
TFX : 211.17 (-0.66%)
LH : 156.55 (+0.28%)
Baxter International (BAX) Q2 Earnings: What's in Store?

Despite an upbeat guidance, lower cyclophosphamide sales are likely to mar Baxter International (BAX) performance in the second quarter 2017.

SYK : 146.19 (-0.82%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
BAX : 62.67 (-0.59%)
Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store?

Varian Medical Systems' (VAR) oncology business strength might drive its performance in Q3.

SYK : 146.19 (-0.82%)
VAR : 103.88 (-0.45%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
Align Technology (ALGN) Q2 Earnings: A Beat in the Cards?

Align Technology (ALGN) might ride high in Q2 banking on growth in the Invisalign space.

SYK : 146.19 (-0.82%)
TMO : 182.18 (+0.35%)
BDX : 205.30 (+0.97%)
ALGN : 158.87 (-0.81%)
What's in Store for athenahealth (ATHN) in Q2 Earnings?

athenahealth Inc. (ATHN) is set to report second-quarter 2017 results on Jul 20.

DXTR : 0.26 (unch)
ATHN : 155.93 (+8.44%)
TMO : 182.18 (+0.35%)
TFX : 211.17 (-0.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab...

See More

Support & Resistance

2nd Resistance Point 183.83
1st Resistance Point 183.01
Last Price 182.18
1st Support Level 181.21
2nd Support Level 180.23

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.